Search

everythinglearnresearchcommunity

for

Search:↓

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

SHBG may be a useful early indicator and treatment target for PCOS.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.